One antidepressant was best at stopping depression returning, big analysis finds
Wednesday, 11 November 2026 · Mental health & wellbeing · Full report · Evidence: Strong
What was found
A combined analysis of earlier research looked at which antidepressants best help people stay well after their depression improves. Over periods of up to one year, escitalopram came out on top 1. People taking it were more likely to keep their symptoms improved and less likely to stop treatment than those on fluoxetine, also known as Prozac 1. Agomelatine and duloxetine ranked just behind escitalopram, fluoxetine placed lower, and sertraline did not stand out as better than the others 1. The gaps between the medicines were small 1.
Who it applies to
The findings concern people prescribed antidepressants for depression, over treatment periods of up to a year 1.
How strong the evidence is
Moderate. This was a systematic review and meta-analysis, which pools the results of many previous studies 1. It covered almost 10,000 people and more than a dozen widely used antidepressants 1. The full news article was read. Several limits apply. The differences between drugs were modest 1. The research looked only as far as one year, and longer-term studies are still needed 1. The results describe patterns across large groups and cannot predict which medicine will suit any one person 1. Side effects such as weight gain, constipation and disturbed sleep can also affect how well a drug fits someone 1.
What it means in practice
According to the report, these results could help doctors and patients when they pick a first antidepressant, with both recovery and staying well in mind 1. The report also states that people who are already stable on their current medicine should not change it just because of this analysis 1. Its view is that any choice needs to weigh the small differences between drugs against side effects and how each person responds 1.